Webinar: Investigating pediatric biomarker reference intervals using new technologies

Accurate platform-specific reference intervals (RIs) established using a healthy pediatric population are essential for interpretation of cytokine expression patterns in children. They provide a baseline to which laboratory test results can be compared in clinical practice. 

In this webinar, attendees will learn:

  • About the CALIPER (Canadian Laboratory Initiative on Pediatric Reference Intervals) program and how it established a comprehensive database of pediatric RIs for over 180 clinical biomarkers.
  • How the stratification of cytokine results based on age and/or sex specific RIs is expected to facilitate more accurate interpretation of cytokine expression patterns.
  • About Ella™, a multi-analyte immunoassay technology the CALIPER team is using to investigate pediatric cytokine profiles.

If you’re an academic, translational, or clinical researcher you don’t want to miss this insightful discussion. Register now for the webinar “Investigating pediatric biomarker reference intervals using new technologies” to attend live on Wednesday, November 3rd at 11 AM ET or to ensure you receive the on-demand recording.

Featured Speakers

Lusia Sepiashvili, Ph.D., DABCC, FCACB

Clinical Biochemist

The Hospital for Sick Children

Dr. Lusia Sepiashvili is a board-certified Clinical Biochemist in the Department of Paediatric Laboratory Medicine at The Hospital for Sick Children. She is involved in numerous collaborative research studies as an Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She co-authored 12 peer-reviewed manuscripts, 3 book chapters, and presented over 20 abstracts internationally and nationally. She serves as the Associate Editor for the AACC NEJM+ Clinical Immunology adaptive learning courses and recently served as a member of the AACC’s COVID 19 Serology Task Force where she contributed to the guidelines for clinical implementation and interpretation of SARS-CoV-2 serologic tests.

Rajiv Pande, Ph.D.

Director, Commercial Immunoassays and Business DevelopmentBio-Techne

Rajiv Pande, Ph.D. is Director of Commercial Immunoassays at Bio-Techne. He was a co-founder of the technology venture that developed and commercialized the Simple Plex (Ella™) platform; subsequently acquired by Bio-Techne. Rajiv has served in technical, commercial and leadership roles across multiple ventures over the last two decades, and has created, developed and commercialized multiple technologies and products.

Date:  Wednesday, November 3, 2021
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar

© 2021 Questex LLC, All right reserved.

685 Third Avenue, 21st Floor New York, NY 10017

Reproduction in whole or part is prohibited.